AZBio News for July 2011

UA Study Plays Key Role in International Lung Research30 year study points to new biomarkers for COPD and other lung diseases.

Dr. Cheryl Nickerson of ASU BiodesignFinal countdown: Space Shuttle Atlantis to carry next generation vaccine candidate on last space voyageIts final trip may open a new era of research into infectious diseases, thanks to space bound experiments conducted by Cheryl Nickerson, and Roy Curtiss III, along with their colleagues at Arizona State University’s Biodesign Institute.

Science Foundation Arizona ups jobs, investment through grants (Phoenix Business Journal)

$2.2M Grant awarded to Fund Heart Failure Study at University of Arizona

Nominations open for the 2011 AZBIO Awards

Phoenix Partnership to Strengthen UA Medical Education

We want to know your name

Biotechnology is changing the way we live, how we think about health, how we combat disease, how we create a more sustainable planet and so much more.  It’s an exciting field in an exciting time and Arizona is a place where bioscience companies, research institutions, and the companies that support them come to  engage, connect, collaborate and grow.

Continue reading

2011 AZBIO Award Nominations Open

Nominations are now open for the 2011 AZBIO Awards. 

(Nominations are open from July 4, 2011 – August 30, 2011)

Join AZBio and the Arizona Biosciences Community in recognising the accomplishment of individuals and companies that represent the best of Arizona bioscience.  Finalists will be announced in September, 2011  and the awards will be announced on the BIG night at the 2011 AZBio Awards on October 13. 2011 at the Sheraton Wild Horse Pass. Click Here for the Nomination Form.

Click here to get all the latest updates on the AZBio Awards and Expo, Check out the agenda, learn about sponsorships and more.

Continue reading

Highlights from AZBIO’s week in DC

After months of planning and collaboration the Arizona contingent packed our bags and headed out to Washington, D.C. to join the bioscience world at the 2011 BIO International Convention.  Erin and I headed out early Saturday morning to Sky Harbor where we boarded our USAIR flight to DC.  Packed in our bags was our new AZBIO information package hot off the press after long hours of collaboration by the AZBIO Marketing and Communications Committee, especially Renee Narvaez of DPR and Lisa Minzey of Affordable Image who worked overtime to get us ready to go .  (You can see the online version here at Scribd. )

Continue reading

BIO Unveils Strategic Initiative to Speed Scientific Breakthroughs, Develop Cures and Grow the Bio-Economy

BIO2011 in Washington DC“Unleashing the Promise of Biotechnology: Advancing American Innovation to Cure Disease and Save Lives” Provides Roadmap for Transformative Policy Changes


WASHINGTON, D.C. (Wednesday, June 29, 2011) – The Biotechnology Industry Organization (BIO) released today a summary of legislative proposals to reform the investment and regulatory environment for biotech innovation. These proposals are designed to unleash the innovation required to cure disease and make the U.S. healthcare system more affordable, efficient, and of higher quality, as well as to foster the development of breakthrough technologies to provide alternative energy sources, combat hunger and protect against bio-terrorism. The policy proposals, released at a press briefing at the 2011 BIO International Convention held here this week, will serve as the organization’s targeted advocacy plan in these two areas.

Continue reading

Washington Watch: the debt ceiling and deficit debate in DC

Clouds over the Capitol.  Photo by Erin Donahue c. AZBioThere has been a lot of talk about budgets and debt ceilings in Washington this week. The negotiations – now taking place between the President and Congressional leaders are fluid, closely held, and difficult to predict. It does not take a PhD to know that Medicare and Medicaid cuts are on the table.

At AZBIO we stay in close communication with our partners at BIO, PhRMA, and AdvaMed so that we can share the latest news with our members.Continue reading

BIO Praises House Passage of Patent Reform Legislation

Press Release from BIO:  The Leahy-Smith America Invents Act will benefit all sectors of U.S. economy

congressWashington, D.C. (June 23, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on the passage of The Leahy-Smith America Invents Act, H.R. 1249, by the House of Representatives:
“Small biotechnology companies rely heavily on their patents to attract investment to fund the lengthy and expensive research and development process necessary to bring breakthrough medical therapies and other products to patients and consumers. Strong intellectual property protection is critical for these companies.

“The Leahy-Smith America Invents Act will bring our patent system into the 21st century. The improvements made by the bill will benefit all sectors of the national economy by enhancing patent quality and the efficiency, objectivity, predictability and transparency of the U.S. patent system.

Continue reading

AdvaMed 2011 Issues Call for Company Presentations

Innovative medical technology companies in all stages of development are eligible to apply to make a 9-minute business development presentation during AdvaMed 2011: The MedTech Conference. The conference will take place in Washington D.C., at the Walter E. Washington Convention Center, September 26-28, and the deadline to apply to present to strategic partners, venture capital firms and angel investors is July 11.Continue reading

Looking Back and Looking Forward

During his 5-year tenure leading at the University of Arizona, President Robert Shelton created both an impressive tenure and laid the foundation for a  lasting legacy.  Shelton will depart the UA at the end of next month, having served five years as the institution’s 19th president. He will become executive director of the Fiesta Bowl, beginning August 1, 2011.   Read more here.

Thank you President Shelton for your  commitment to the U of A, to our bioscience  community and to our state.Continue reading